Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Titre (en) » - entrée « monoamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
monkeys < monoamine < monoaminergic  Facettes :

List of bibliographic references indexed by monoamine

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000780 (2010) Tamar Goren [Israël] ; Liat Adar [Israël] ; Nissim Sasson [Israël] ; Yoni M. Weiss [Israël]Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO‐B) Inhibitor Rasagiline
001008 (2007) Fernandez [États-Unis] ; Chen [États-Unis]Monoamine Oxidase‐B Inhibition in the Treatment of Parkinson's Disease
001178 (2006) Moussa B. H. Youdim [Israël] ; Dale Edmondson [États-Unis] ; Keith F. Tipton [Irlande (pays)]The therapeutic potential of monoamine oxidase inhibitors
001293 (2006) Charles E. Glatt [États-Unis] ; Angelika D. Wahner ; Daniel J. White [Royaume-Uni] ; Andres Ruiz-Linares [Royaume-Uni] ; Beate RitzGain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women
001565 (2004) M. Białecka ; M. Dro Dzik ; G. Kłodowska-Duda ; K. Honczarenko ; B. Gawro Ska-Szklarz ; G. Opala ; J. Stankiewicz [Pologne]The effect of monoamine oxidase B (MAOB) and catechol‐O‐methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
001575 (2004) Sid Gilman [États-Unis] ; Robert A. Koeppe [États-Unis] ; Roderick Little [États-Unis] ; Hyonggin An [États-Unis] ; Larry Junck [États-Unis] ; Bruno Giordani [États-Unis] ; Carol Persad [États-Unis] ; Mary Heumann [États-Unis] ; Kris Wernette [États-Unis]Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease
001600 (2004) Rinat Tabakman [Israël] ; Shimon Lecht [Israël] ; Philip Lazarovici [Israël]Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?
001606 (2004) Natalie J. Ives ; Rebecca L. Stowe ; Joanna Marro ; Carl Counsell ; Angus Macleod ; Carl E. Clarke ; Richard Gray ; Keith WheatleyMonoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
001660 (2004) Paola Costa-Mallen [États-Unis] ; Zahra Afsharinejad [États-Unis] ; Samir N. Kelada [États-Unis] ; Lucio G. Costa [États-Unis, Italie] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; W. T. Longstreth Jr. [États-Unis] ; Hannah-Malia A. Viernes [États-Unis] ; Federico M. Farin [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis]DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls
001C02 (2000) M. Jimenez Del Rio [Colombie] ; C. Velez-Pardo [Colombie]Molecular mechanism of monoamine toxicity in Parkinson’s disease: hypothetical cell death model
002057 (1997) Paola Costa [États-Unis] ; Harvey Checkoway [États-Unis] ; Drew Levy [États-Unis] ; Terri Smith-Weller [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Lucio G. Costa [États-Unis]Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease
002159 (1996) T. Salonen ; Antti Haapalinna ; Esa Heinonen ; Jaana Suhonen [États-Unis] ; Antti HervonenMonoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity
002283 (1995) F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France]Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine
002300 (1995) Juha O. Rinne [Finlande] ; Arto Laihinen [Finlande] ; Kjell N Gren [Finlande] ; Hanna Ruottinen [Finlande] ; Ulla Ruotsawnen [Finlande] ; Urpo K. Rinne [Finlande]PET examination of the monoamine transporter with [11c]β‐CIT and [11c]β‐CFT in early parkinson's disease
002424 (1994) Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
002436 (1994) Gokhan S. Hotamisligil [États-Unis] ; A. Sule Girmen [États-Unis] ; J. Stephen Fink [États-Unis] ; Elizabeth Tivol [États-Unis] ; Christo Shalish [États-Unis] ; James Trofatter [États-Unis] ; John Baenziger [États-Unis] ; Shirley Diamond [États-Unis] ; Charles Markham [États-Unis] ; Jack Sullivan [États-Unis] ; John Growdon [États-Unis] ; Xandra O. Breakefield [États-Unis]Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
002450 (1994) A. Espino [Espagne] ; S. Ambrosio [Espagne] ; R. Bartrons [Espagne] ; G. Bendahan [Espagne] ; M. Calopa [Espagne]Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+
002532 (1993) M. Palmer [États-Unis] ; T. Dekosky [États-Unis]Monoamine neurons in aging and Alzheimer's disease
002533 (1993) H. Tohgi [Japon] ; T. Abe [Japon] ; S. Takahashi [Japon] ; J. Takahashi [Japon] ; Y. Nozaki [Japon] ; M. Ueno [Japon] ; T. Kikuchi [Japon]Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes
002549 (1993) H. Heinonen [Finlande] ; M. Savij Rvi [Finlande] ; M. Kotila [Finlande] ; A. Hajba [Finlande] ; M. Scheinin [Finlande]Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease
002552 (1993) H. Youdim [Israël] ; P. Riederer [Allemagne]Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "monoamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "monoamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    monoamine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024